skip to content


GELSEMIUM for anxiety, pain in face, trigeminal neuralgia treatment, facial nerve

WALA Heilmittel GmbH

Sale price £31.50 Regular price £40.00

Tax included. Shipping calculated at checkout.

GELSEMIUM for anxiety, pain in face, trigeminal neuralgia treatment, facial nerve COMP. Globules 20 g

Homeopathic medicine for oral use GELSEMIUM for anxiety, pain in face, trigeminal neuralgia treatment, facial nerve

 

Registered homeopathic medicinal product, therefore no indication of a therapeutic indication. Medical advice should be sought if symptoms persist while using this medicine. For risks and side effects, read the leaflet and ask your doctor or pharmacist.

Anthroposophic medicinal product for influenza infections with head involvement.

active GELSEMIUM for anxiety, pain in face, trigeminal neuralgia treatment, facial nerve ingredients

  • 10 mg Bryonia cretica ferm 33b D2
  • 20 mg Gelsemium e radice ferm 35b D2,D14 per 10 mg
  • 10 mg Vivianite D7

GELSEMIUM for anxiety, pain in face, trigeminal neuralgia treatment, facial nerve excipients

  • sucrose
  • lactose

gelsemium benefits:

the root and underground stem (rhizome) of gelsemium are used to make medicine. Gelsemium is used as a painkiller for migraine headaches, for anxiety and for face pain (trigeminal neuralgia) caused by certain facial nerves. It is also used for asthma and other breathing problems.

Bryonia cretica benefits:

Bryonia, also called bryony, is a plant-based homeopathic remedy that's been used to relieve constipation, upset stomach, and fluid retention. It's also been used to treat chronic conditions such as arthritis, cancer, and liver disease.

Vivianite benefits:

Vivianite is a stone full of peace and love and will relight the care you may have lost for the closest people around you. As well as unlocking the heart, Vivianite also assists in removing negativity and unwanted energies from your mind, body, and auric field.

Method of application:
Dissolve under the tongue.

Composition:
The following are processed in 10 g Globuli velati: Active ingredients: Bryonia cretica ferm 33b Dil. D2 0.1g; Gelsemium sempervirens e rhizoma ferm 35b Dil. D2 (HAB, method 35b) 0.1 g; Gelsemium sempervirens e rhizoma ferm 35b Dil. D14 (HAB, Method 35b) 0.1g; Vivianite Dil. D7 0.1g. (The ingredients are potentised together over two stages.) Contains sucrose (sucrose/sugar) and lactose.

Areas of application
according to anthroposophical knowledge of man and nature. These include: influenza infections, particularly those involving the head; neuralgiform pain conditions.

Contraindications:
None known.

Precautions for use and warnings:
If you have symptoms that last longer than a week, if you have shortness of breath, fever or if you have purulent or bloody sputum, you should consult your doctor. What do you have to consider during pregnancy and breastfeeding? Like all medicines, Gelsemium comp. only be used during pregnancy and breastfeeding after consulting a doctor. This medicine contains sucrose and lactose. Please take Gelsemium comp. only after consulting your doctor if you know that you suffer from an
intolerance to certain sugars.

Interactions with other agents:
None known.

 

Dosage GELSEMIUM for anxiety, pain in face, trigeminal neuralgia treatment, facial nerve:


Unless otherwise directed, children under 6 years of age let 3-5 globules velati dissolve under the tongue twice a day. Adults and children from the age of 6 years dissolve 5-10 globules
velati under the tongue twice a day. For infants, it is advisable to dissolve the specified amount of Globuli velati in a small amount of water or unsweetened tea before administration.

Duration of use:
The treatment of an acute illness should be completed after 2 weeks. If there is no improvement within 2-5 days, consult a doctor. The duration of treatment of chronic diseases requires consultation with the doctor.

Side effects:
None known. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This also applies to side effects that are not listed in this leaflet.